Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;73(4):367-75.
doi: 10.4103/0250-474X.95608.

Noninvasive routes of proteins and peptides drug delivery

Jitendra  1 , P K Sharma, Sumedha Bansal, Arunabha Banik
Affiliations

Noninvasive routes of proteins and peptides drug delivery

Jitendra et al. Indian J Pharm Sci. 2011 Jul.

Abstract

Recent advances in the field of pharmaceutical biotechnology have led to the formulation of many protein and peptide-based drugs for therapeutic and clinical application. The route of administration has a significant impact on the therapeutic outcome of a drug. The needle and syringe is a well established choice of protein and peptide delivery which has some drawback related to patient and to formulation such as pain, cost, sterility etc. Thus, the noninvasive routes which were of minor importance as parts of drug delivery in the past have assumed added importance in protein and peptide drug delivery and these include nasal, ophthalmic, buccal, vaginal, transdermal and pulmonary routes. The pharmaceutical scientists have some approaches to develop the formulations for protein and peptide delivery by noninvasive routes. But, due to the physiochemical instability and enzymatic barrier of proteins and peptides there are several hurdle to develop suitable formulation. So there is need of penetration enhancers, enzyme inhibitors and suitable vehicles for noninvasive delivery to increase the bioavailability. In this review, the aim is to focus on the approaches to formulation of protein and peptide based drug administration by noninvasive route.

Keywords: Enzymes; insulin; nanoparticles; noninvasive route; protein and peptide.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. [Last accessed on 2010 June 13]. Available from: http://www.Drugdeliverytech-online.com .
    1. Washington DC: 2006. Tauzin, Report: Biotechnology Medicines in Development, Pharmaceutical Research and Manufacturers Association.
    1. Moore JV. Dose-response curve after in vivo experimental chemotherapy: Influence of route of administration on biologicals outcomes. Cancer Chemother Pharmacol. 1985;15:91. - PubMed
    1. Benet LZ. Effect of route of administration and distribution on drug action. J Pharmacokinet Biopharm. 1978;6:559–85. - PubMed
    1. Pettit DK, Gombotz WR. The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals. Trends Biotechnol. 1998;16:343–9. - PubMed

LinkOut - more resources